Bg pattern

RABEPRAZOL KRKA 10 mg GASTRO-RESISTANT TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use RABEPRAZOL KRKA 10 mg GASTRO-RESISTANT TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Rabeprazol Krka 10 mg Gastro-Resistant Tablets EFG

Rabeprazole Sodium

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Rabeprazol Krka and what is it used for
  2. What you need to know before you take Rabeprazol Krka
  3. How to take Rabeprazol Krka
  4. Possible side effects
  5. Storage of Rabeprazol Krka
  6. Contents of the pack and other information

1. What is Rabeprazol Krka and what is it used for

Rabeprazol Krka contains the active substance rabeprazole sodium. Rabeprazole belongs to a group of medicines called “Proton Pump Inhibitors” (PPIs), which reduce the amount of acid produced by the stomach.

Rabeprazole is used to treat the following diseases:

  • “Gastroesophageal Reflux Disease” (GERD), which may include symptoms of acidity. The cause of GERD is the passage of acid and food from the stomach to the esophagus.
  • Stomach ulcers or ulcers in the upper part of the intestine (duodenal ulcers). If these ulcers are infected with a bacterium called “Helicobacter pylori” (H. pylori), you will need to take antibiotics. Taking rabeprazole and antibiotics together will eliminate the infection and the ulcer will heal. It will also stop the infection and the recurrence of the ulcer.
  • Zollinger-Ellison syndrome, in which the stomach produces too much acid.
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Rabeprazol Krka

Do not takeRabeprazol Krka

  • If you are allergic to rabeprazole sodium or any of the other ingredients of this medicine (listed in section 6).
  • If you are pregnant or think you may be pregnant.
  • If you are breast-feeding.

Do not take rabeprazole if you are in any of the above situations. If you are not sure, consult your doctor or pharmacist before taking rabeprazole.

See also the section on pregnancy, breast-feeding, and fertility.

Warnings and precautions

Consult your doctor or pharmacist before starting to take rabeprazole.

  • If you are allergic to other proton pump inhibitors or to “substituted benzimidazoles”.
  • In some patients, blood and liver problems have been observed, but they often improve when treatment with rabeprazole is interrupted.
  • If you have a stomach tumor.
  • If you have ever had liver problems.
  • If you are taking atazanavir - for HIV infection.
  • If you have reduced body stores or risk factors for low vitamin B12 levels and receive long-term treatment with rabeprazole. Like all acid-reducing agents, rabeprazole may reduce the absorption of vitamin B12.
  • If you have ever had a skin reaction after treatment with an acid-reducing medicine similar to rabeprazole.
  • If you get a skin rash, especially in areas of the skin exposed to the sun, consult your doctor as soon as possible, as it may be necessary to interrupt treatment with rabeprazole. Remember to mention any other symptoms you may notice, such as joint pain.
  • If you are scheduled to have a specific blood test (Chromogranin A).
    • During treatment with rabeprazole, kidney inflammation can occur. The signs and symptoms include: decreased urine volume or blood in the urine and/or hypersensitivity reactions such as fever, skin rash, and joint stiffness. You should report these signs to your doctor.

If you are in doubt about any of the above, consult your doctor or pharmacist before taking rabeprazole.

If you experience severe diarrhea (watery or bloody) with symptoms such as fever, abdominal pain, or tenderness, stop taking rabeprazole and consult your doctor immediately.

If you are taking a proton pump inhibitor like rabeprazole, especially for a period of more than one year, you may have a slightly increased risk of hip, wrist, or spine fractures. Inform your doctor if you have osteoporosis or if you are taking corticosteroids (which can increase the risk of osteoporosis).

Children

Rabeprazole should not be used in children.

Taking Rabeprazol Krka with other medicines

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. This includes medicines obtained without a prescription and herbal medicines.

In particular, tell your doctor or pharmacist if you are taking any of the following medicines:

  • Ketoconazole or itraconazole - used to treat fungal infections. Rabeprazole may decrease the amount of these medicines in the blood. Your doctor may need to adjust the dose.
  • Atazanavir - used to treat HIV infection. Rabeprazole may decrease the amount of this type of medicine in the blood and should not be used together.
  • Methotrexate (a chemotherapy medicine used at high doses to treat cancer) - if you are taking a high dose of methotrexate, your doctor may temporarily stop your treatment with rabeprazole.

If you are in doubt about any of the above, consult your doctor or pharmacist before taking rabeprazole.

Pregnancy, breast-feeding, and fertility

  • Do not take rabeprazole if you are pregnant or think you may be pregnant.
  • Do not take rabeprazole during breast-feeding or if you plan to start breast-feeding.

If you are pregnant or breast-feeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Driving and using machines

You may feel drowsy while taking rabeprazole. If this happens, do not drive or use tools or machines.

3. How to take Rabeprazol Krka

Follow the instructions for administration of this medicine exactly as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.

Taking this medicine

  • Only remove a tablet from the blister when it is time to take your medicine.
  • Swallow the tablets whole with a little water. Do not crush or chew the tablets.
  • Your doctor will tell you how many tablets to take and the duration of your treatment, which will depend on your indication.

If you are taking this medicine for a long time, your doctor will want to monitor you.

Adults and elderly patients

For “Gastroesophageal Reflux Disease” (GERD)

Treatment of moderate to severe symptoms (symptomatic GERD)

  • The usual dose is one 10 mg rabeprazole tablet once a day for up to 4 weeks.
  • Take the tablet in the morning before eating.
  • If your symptoms recur after 4 weeks of treatment, your doctor will tell you to take one rabeprazole 10 mg tablet as needed.

Treatment of more severe symptoms (erosive or ulcerative GERD)

  • The usual dose is one 20 mg rabeprazole tablet once a day for 4 to 8 weeks.
  • Take the tablet in the morning before eating.

Long-term treatment of symptoms (maintenance GERD)

  • The usual dose is one 10 or 20 mg rabeprazole tablet once a day for as long as your doctor has indicated.
  • Take the tablet in the morning before eating.
  • Your doctor will want to see you at regular intervals to monitor your symptoms and dose.

For stomach ulcers (peptic ulcers)

  • The usual dose is one 20 mg rabeprazole tablet once a day for 6 weeks.
  • Take the tablet in the morning before eating.
  • Your doctor may tell you to take rabeprazole for another 6 weeks if your symptoms do not improve.

For ulcers in the intestine (duodenal ulcers)

  • The usual dose is one 20 mg rabeprazole tablet once a day for 4 weeks.
  • Take the tablet in the morning before eating.
  • Your doctor may tell you to take rabeprazole for another 4 weeks if your symptoms do not improve.

For ulcers caused by H. pylori infection and to prevent recurrence

  • The usual dose is one 20 mg rabeprazole tablet twice a day for 7 days.
  • Your doctor will also tell you to take antibiotics called amoxicillin and clarithromycin.

For more information on the other medicines used to treat H. pylori, read the package leaflets for each of them.

Zollinger-Ellison syndrome where the stomach produces too much acid

  • The usual dose is three 20 mg rabeprazole tablets once a day at the start.
  • Your doctor may adjust the dose depending on how you respond to treatment.

If you are on long-term treatment, you will need to see your doctor at regular intervals for dose and symptom review.

Children:this medicine should not be used in children.

Patient with liver problems. You should consult your doctor, who will be particularly careful when starting and during treatment with rabeprazole.

If you take more Rabeprazol Krka than you should

If you take more rabeprazole than you should, talk to your doctor or go to a hospital immediately. Take the medicine with you.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount ingested.

If you forget to take Rabeprazol Krka

  • If you forget to take a tablet, take it as soon as you remember. However, if it is almost time to take the next tablet, skip the missed dose and continue as usual.
  • If you forget to take your medicine for more than 5 days, consult your doctor before taking more medicine.
  • Do not take a double dose (two doses at the same time) to make up for the missed dose.

If you stop taking Rabeprazol Krka

Relief of symptoms usually occurs before the ulcer is completely healed. It is important that you do not stop treatment until your doctor tells you to.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Stop taking rabeprazole and contact your doctor immediately if you notice any of the following side effects – you may need urgent medical treatment:

  • Allergic reactions - the signs may include: sudden swelling of the face, difficulty breathing, or low blood pressure that can cause fainting or collapse.
  • Frequent infections, such as sore throat or high temperature (fever), or ulcers in the mouth or throat.
  • Bruising or bleeding easily.

These side effects are rare (may affect up to 1 in 1,000 people).

  • Severe skin blisters or rashes, or sores or ulcers in your mouth and throat.

These side effects are very rare (may affect up to 1 in 10,000 people).

Other possible side effects:

Common (may affect up to 1 in 10 people):

  • Infections.
  • Difficulty sleeping.
  • Headache or dizziness.
  • Cough, runny nose, or sore throat (pharyngitis).
  • Effects on the stomach or intestine such as stomach pain, diarrhea, gas (flatulence), nausea, vomiting, or constipation.
  • Pain or back pain.
  • Weakness or flu-like symptoms.
  • Benign polyps in the stomach.

Uncommon (may affect up to 1 in 100 people):

  • Feeling nervous or drowsy.
  • Chest infection (bronchitis).
  • Painful sinuses and blocked nose (sinusitis).
  • Dry mouth.
  • Indigestion or belching.
  • Skin rash or redness.
  • Muscle or leg or joint pain.
  • Fractures in the hip, wrist, and spine.
  • Urinary tract infection (urinary tract infection).
  • Chest pain.
  • Chills or fever.
  • Changes in liver function (observed in blood tests).

Rare (may affect up to 1 in 1,000 people):

  • Lack of appetite (anorexia).
  • Depression.
  • Hypersensitivity (including allergic reactions).
  • Visual disturbances.
  • Inflamed mouth (stomatitis) or taste disorders.
  • Stomach upset or stomach pain.
  • Liver problems, including yellowing of the skin and whites of the eyes (jaundice).
  • Itchy rash or blisters.
  • Sweating.
  • Kidney problems.
  • Weight gain.
  • Changes in white blood cells (observed in blood tests) that can cause frequent infections.
  • Decreased platelet count that can cause bleeding or bruising more easily than normal.

Other possible side effects (frequency not known - cannot be estimated from the available data):

  • Swelling of the breasts in men.
  • Fluid retention.
  • Inflammation of the intestine (leading to diarrhea).
  • Low sodium levels in the blood that can cause tiredness and confusion, muscle spasms, convulsions, and coma.
  • Patients who have previously had liver problems may very rarely develop encephalopathy (brain disease).
  • Skin rash, possibly with joint pain.

If you are taking rabeprazole for more than three months, it is possible that your blood magnesium levels may decrease. Low magnesium levels can cause tiredness, muscle contractions, disorientation, convulsions, dizziness, and increased heart rate. If you have any of these symptoms, consult your doctor immediately. Low magnesium levels can also lead to a decrease in blood potassium or calcium levels. Your doctor may decide to perform periodic blood tests to monitor magnesium levels.

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible that they are not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Rabeprazol Krka

Keep this medicine out of the sight and reach of children.

Do not use rabeprazole after the expiration date stated on the packaging and on the blister after EXP. The expiration date is the last day of the month indicated.

Store in the original package to protect from moisture and light.

Do not store above 30°C.

Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines you no longer need in the SIGRE collection point at the pharmacy. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.

6. Contents of the pack and other information

Composition ofRabeprazol Krka

  • The active substance is rabeprazole sodium. Each gastro-resistant tablet contains 10 mg of rabeprazole sodium, equivalent to 9.42 mg of rabeprazole.
  • The other ingredients are mannitol (E-421), light magnesium oxide (E-530), hydroxypropylcellulose (E-463), low-substitution hydroxypropylcellulose (E-463), and magnesium stearate (E-572) in the core, and ethylcellulose (E-462), light magnesium oxide (E-530), hypromellose phthalate, mono- and diacetin (E-472a), talc (E-553b), titanium dioxide (E-171), and red iron oxide (E-172) in the coating.

Appearance of the product and pack contents

The 10 mg gastro-resistant tablets are pink-orange, biconvex, and round with a beveled edge.

They are available in blisters in packs of 28 gastro-resistant tablets.

Marketing authorization holder and manufacturer

KRKA, d.d. Novo mesto

Šmarješka cesta 6

8501 Novo mesto

Slovenia

You can request more information about this medicine by contacting the Local Representative of the Marketing Authorization Holder:

Krka Farmacéutica, S.L.

C/ Anabel Segura 10

28108 Alcobendas, Madrid

Spain

Date of the last revision of this leaflet:

"Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/"

Online doctors for RABEPRAZOL KRKA 10 mg GASTRO-RESISTANT TABLETS

Discuss questions about RABEPRAZOL KRKA 10 mg GASTRO-RESISTANT TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for RABEPRAZOL KRKA 10 mg GASTRO-RESISTANT TABLETS?
RABEPRAZOL KRKA 10 mg GASTRO-RESISTANT TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in RABEPRAZOL KRKA 10 mg GASTRO-RESISTANT TABLETS?
The active ingredient in RABEPRAZOL KRKA 10 mg GASTRO-RESISTANT TABLETS is rabeprazole. This information helps identify medicines with the same composition but different brand names.
How much does RABEPRAZOL KRKA 10 mg GASTRO-RESISTANT TABLETS cost in pharmacies?
The average pharmacy price for RABEPRAZOL KRKA 10 mg GASTRO-RESISTANT TABLETS is around 12.19 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures RABEPRAZOL KRKA 10 mg GASTRO-RESISTANT TABLETS?
RABEPRAZOL KRKA 10 mg GASTRO-RESISTANT TABLETS is manufactured by Krka D.D. Novo Mesto. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of RABEPRAZOL KRKA 10 mg GASTRO-RESISTANT TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether RABEPRAZOL KRKA 10 mg GASTRO-RESISTANT TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to RABEPRAZOL KRKA 10 mg GASTRO-RESISTANT TABLETS?
Other medicines with the same active substance (rabeprazole) include PARIET 10 mg GASTRO-RESISTANT TABLETS, PARIET 20 mg GASTRO-RESISTANT TABLETS, RABEPRAZOL ALMUS 20 mg GASTRO-RESISTANT TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media